Firm / Organisation

Simpson Thacher & Bartlett LLP

This content is provided by Simpson Thacher & Bartlett LLP.

Chairman, Executive Committee: William R. Dougherty
Administrative Partners: Jennifer Hobbs, Sasan Mehrara
Head of Asia Practice: David A. Sneider
Head of China Practice: Celia Lam
Number of partners worldwide: 190
Number of other lawyers worldwide: Approx. 700
Asia Pacific Offices: Beijing, Hong Kong, Tokyo
International Offices: Houston, London, Los Angeles, New York, Palo Alto, São Paulo and Washington, DC

Firm Overview:
Simpson Thacher & Bartlett LLP is widely recognised as one of the preeminent law firms in the world. The firm represents clients with a commitment to hard work, excellence and integrity. The firm has a strong track record in representing leading Asian and global companies, financial institutions and investment firms on significant and complex capital markets, banking and cross-border M&A transactions involving Greater China, Japan, Korea, India, Australia and other parts of Asia and around the globe. The Asian investment funds team reflects the strength of the firm’s preeminent private equity funds practice globally. Through its Asia litigation practice group, the firm provides its Asia-based clients with a comprehensive offering of litigation services, including antitrust, IP, international arbitration, securities and government and internal investigation matters. The firm advises on Hong Kong local law in addition to US and English law. Many attorneys in Asia are native speakers of Mandarin Chinese, Japanese or Korean and have considerable transaction experience throughout the region.

Main Areas of Practice:
■ Capital Markets
■ M&A & Private Equity
■ Banking & Finance
■ Real Estate
■ Investment Funds
■ Asia Litigation Practice Group

Capital Markets:
■ Alibaba Group in its US$25 billion IPO on the NYSE and its US$11 billion secondary listing and public offering on the HKSE
■ IPOs of Chinese companies on both US and HK exchanges including Huatai Securities, Qudian, BEST Inc., Zhongliang, Qutoutiao and FIT Hon Teng
■ IPOs of major Japanese companies including LINE, Mercari, Kyushu Railway and Japan Post
■ IPOs of Korean companies on the KRX including Lotte REIT, Samsung BioLogics, Doosan Bobcat and Celltrion Healthcare
■ Debt and equity offerings by Alibaba, Ant Financial, Baozun, Dai-ichi Life Insurance, Daiwa House REIT, Hanwha Life, KEPCO, Kia Motors, Mitsubishi UFJ, Panasonic, Republic of Korea, Shinhan Bank, Sumitomo Mitsui, Suntory, Takeda Pharmaceutical and Weibo

M&A & Private Equity:
■ Alibaba in many acquisitions and investments, including Ele.me, Lyft, Tokopedia and Trendyol, and partnership with Starbucks
■ Ant Financial in its US$14 billion Series C equity financing and investments in hellopay, India’s Paytm, Indonesia’s Emtek, Malaysia’s Touch ’n Go, Korea’s Kakaopay, Bangladesh’s bKash, Pakistan’s Telenor Microfinance Bank and Philippines’ Mynt
■ Calsonic Kansei in its US$7.1 billion acquisition of Magneti Marelli
■ China National Chemical Corporation in its US$43 billion acquisition of Syngenta
■ ‘Going private’ transactions including of LCY Chemicals, iKang, AutoNavi and Homeinns
■ Blackstone Capital Partners and Blackstone Tactical Opportunities in multiple matters, including Blackstone’s acquisition of AYUMI Pharmaceutical
■ KKR in its tender offers to acquire Japan’s Calsonic Kansei, Hitachi Koki and Hitachi Kokusai Electric and multiple acquisitions or investments in Asia including: India (IndiGrid, Ramky Enviro), Indonesia (Japfa Comfeed), Korea (LS Auto), Malaysia (Weststar Aviation), Metro Pacific Hospitals (Philippines) and Vietnam (Masan)
■ SK Holdings in its acquisition of AMPAC Fine Chemicals

Banking & Finance:
■ KKR’s acquisitions of LCY Chemical, Calsonic Kansei, Hitachi Koki and Hitachi Kokusai Electric
■ Blackstone’s acquisition of AYUMI Pharmaceutical
■ Ant Financial’s syndicated loan refinancing
■ Calsonic Kansei’s acquisition of Magneti Marelli; SK Holdings’ acquisition of AMPAC Fine Chemicals; and ChemChina’s acquisition of Syngenta
■ Blackstone Real Estate’s investments in properties in PRC, Australia and other Asian countries

Real Estate:
■ Blackstone Real Estate Partners in its acquisition of 50% of Taubman Asia’s interests in three Asia-based shopping centers; the formation of its JV with Vanke to invest in logistics properties in China; its investment in SCP Company; and various financing matters
■ KKR in the investment in a mixed-use real estate project under development in Seoul’s Gangnam Business District
■ Blackstone Real Estate in its investments in properties in Australia, India and Singapore Investment Funds: Counsel to sponsors on the formation of:
■ Aspirant’s ¥50 billion AG III series
■ Affinity’s US$6 billion fifth Asia Pacific fund
■ Blackstone’s US$7.1 billion second pan-Asia real estate fund and US$2.3 billion first pan-Asia buyout fund
■ Carlyle’s US$6.55 billion fifth pan-Asia fund
■ Integral’s ¥73 billion third Japan buyout fund
■ J-Star’s ¥48.5 billion Fund IV series
■ Polaris Capital’s ¥75 billion second fund series
■ Yunfeng’s US$2.5 billion third China-focused private equity fund
■ Zebra Global’s US$800 million debut fund

Litigation:
■ Alibaba in a dozen federal and California state securities litigations and an SEC investigation related to its historic IPO
■ US-listed, Asia-based clients in nonpublic DOJ, SEC and FINRA investigations
■ Daiichi Sankyo in recovering over US$525 million in ICC arbitration on fraud claims against the sellers of Indian generic pharma company Ranbaxy
■ Danone as claimant in UNCITRAL arbitration against Fonterra relating to the 2013 botulism crisis across Asia-Pacific
■ Elpida, Hannstar, Innolux, LG Display, Stanley Electric and Diamond Electric in global price-fixing cartel litigations

Contributions

Total 2 contributions

Private Equity 2019 Introduction

Amy Mahon

Read now
Private Equity 2019 Law and Practice in UK

Amy Mahon

Read now